Schuyler Kevin
SEC insider (Form 3/4/5 filer). CIK 0001718094. Director at ADIAL PHARMACEUTICALS, INC. (ADIL) and 2 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Apr 7, 2026. Located in GLEN ALLEN, VA.
Companies Schuyler Kevin has filed insider reports for
- ADIAL PHARMACEUTICALS, INC. (ADIL): Director
- Twin Vee PowerCats, Co. (VEEE): Director
- Forza X1, Inc. (FRZA): Director
Schuyler Kevin
CIK: 0001718094
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Apr 7, 2026ADIL
ADIAL PHARMACEUTICALS, INC.
AwardDirect9.2K shares- - Mar 19, 2026VEEE
Twin Vee PowerCats, Co.
PurchaseDirect25K shares at avg. $0.41$10K - May 29, 2025ADIL
ADIAL PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
28K shares- - May 19, 2025VEEE
Twin Vee PowerCats, Co.
AwardDirectStock Option (Right to Buy)
3K shares- - Nov 26, 2024FRZA
Forza X1, Inc.
DispositionDirect100K shares- - Nov 26, 2024VEEE
Twin Vee PowerCats, Co.
AwardDirect61.2K shares- - Sep 17, 2024FRZA
Forza X1, Inc.
PurchaseDirect90.7K shares at avg. $0.30$27K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 7, 2026 |  ADIL ADIAL PHARMACEUTICALS, INC. | Award | 9,185 | - | $0 | Direct |
| Mar 19, 2026 |  VEEE Twin Vee PowerCats, Co. | Purchase | 25,000 | $0.41 | $10,165 | Direct |
| May 29, 2025 | ADIL ADIAL PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 28,000 | - | - | Direct |
| May 19, 2025 | VEEE Twin Vee PowerCats, Co. | Award Stock Option (Right to Buy) | 3,000 | - | - | Direct |
| Nov 26, 2024 |  FRZA Forza X1, Inc. | Disposition | 100,000 | - | $0 | Direct |
| Nov 26, 2024 | VEEE Twin Vee PowerCats, Co. | Award | 61,166 | - | $0 | Direct |
| Sep 17, 2024 | FRZA Forza X1, Inc. | Purchase | 90,668 | $0.30 | $27,200 | Direct |
1-7 of 7 transactions